What is Global Positron Emission Computed Tomography Market?
The Global Positron Emission Computed Tomography (PET) Market is a significant segment of the medical imaging technology industry. PET is a type of nuclear medicine imaging that uses small amounts of radioactive materials, a special camera, and a computer to evaluate organ and tissue functions. This technology is primarily used to detect cancer, heart problems, brain disorders, and other diseases. It provides detailed information about the body's function and metabolism, unlike other imaging techniques that focus on structure. The Global PET Market is a vast and complex network of manufacturers, suppliers, and consumers spread across the world. In 2022, the market was valued at US$ 762.4 million and is expected to reach US$ 922.3 million by 2029. This growth is driven by the increasing prevalence of chronic diseases, advancements in technology, and the growing demand for effective diagnostic systems. However, the high cost of PET scanners and the lack of skilled professionals are some of the challenges faced by this market.
Direct Imaging, Indirect Imaging, Alternative Imaging in the Global Positron Emission Computed Tomography Market:
The Global PET Market is segmented based on the type of imaging, which includes Direct Imaging, Indirect Imaging, and Alternative Imaging. Direct Imaging involves the detection of gamma rays emitted directly from the radioactive tracer. This method provides high-resolution images and is commonly used in oncology. Indirect Imaging, on the other hand, involves the detection of annihilation photons produced when positrons from the tracer interact with electrons in the body. This method is used in cardiology and neurology due to its ability to provide functional information about the heart and brain. Alternative Imaging is a newer method that combines the advantages of both Direct and Indirect Imaging. However, it is still in the experimental stage and is not widely used. Each of these imaging types has its own advantages and disadvantages, and their usage depends on the specific requirements of the diagnosis.
Brain Diseases, Cancer, Cardiovascular Diseases, Others in the Global Positron Emission Computed Tomography Market:
The Global PET Market finds its applications in various areas such as Brain Diseases, Cancer, Cardiovascular Diseases, among others. In the field of neurology, PET is used to diagnose and monitor the progression of brain disorders such as Alzheimer's disease, Parkinson's disease, and epilepsy. It provides valuable information about the brain's metabolism and function, which helps in the development of effective treatment plans. In oncology, PET is used to detect and stage different types of cancer. It helps in determining the exact location and size of the tumor, assessing the effectiveness of the treatment, and detecting any recurrence of the disease. In cardiology, PET is used to evaluate the heart's function and detect any abnormalities. It helps in diagnosing heart diseases at an early stage and assessing the risk of heart attack. Other applications of PET include the diagnosis of infectious diseases, inflammation, and other disorders.
Global Positron Emission Computed Tomography Market Outlook:
The Global PET Market outlook is promising, with a steady growth rate projected for the coming years. In 2022, the market was valued at US$ 762.4 million and is expected to reach US$ 922.3 million by 2029, growing at a CAGR of 2.7%. The market is dominated by GE, which holds a 37% market share, followed by Siemens Healthcare with a 39% share. Philips Healthcare also has a significant presence in the market. This report provides a comprehensive overview of the Global PET Market, offering both quantitative and qualitative analysis. It aims to assist readers in developing business strategies, assessing the market competition, analyzing their position in the market, and making informed business decisions.
| Report Metric | Details |
| Report Name | Positron Emission Computed Tomography Market |
| Accounted market size in 2023 | US$ 786.1 million |
| Forecasted market size in 2029 | US$ 922.3 million |
| Base Year | 2023 |
| Forecasted years | 2023 - 2029 |
| Segment by Type |
|
| Segment by Application |
|
| Segment by Region |
|
| By Company | Philips Healthcare, Siemens Healthcare, GE, Hitachi, Toshiba, Topgrade HealthCare, Neusoft, United Imaging, SinoVision, Arrays Medical |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
